Aims

• To provide knowledge on an integrated approach of imaging in the diagnosis, treatment and management of hepatic, pancreatic and GI neoplasms.
• To understand how information obtained by imaging can be used for clinical decision making, treatment planning and response assessment.
• To learn about new imaging methods, the clinically relevant questions and how the answers impact treatment decision making
• To attend smaller groups workshops simulating multidisciplinary tumour boards.

Target Group

The target group consists of senior residents and specialist involved in the diagnosis and management of patients with hepatic, pancreatic and GI tract neoplasms (such as radiologists, nuclear medicine specialists, surgeons, oncologists, gastroenterologists and radiotherapists), who are interested to learn and improve their knowledge on an optimal approach to multidisciplinary treatment management exploiting the use of imaging.

­­­Thursday, April 13, 2023

CME European credits:
“The ESGAR Hepatobiliary and GI Tract Tumours Workshop, Sevilla, Spain, 13/04/2023-14/04/2023 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 11 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.”

“Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

“Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.”